...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith new VP
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Same firm that found Mike Sweeney for Resverlogix

http://thetoftgroup.com/news-and-events/press/toft-group-completes-executive-search-for-resverlogix-corp-tsxrvx-in-calgary-canada/ 

 

masila

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply